Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-25-068703
Filing Date
2025-07-17
Accepted
2025-07-17 17:01:02
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 tm2521015-1_s3.htm S-3 247977
2 EXHIBIT 5.1 tm2521015d2_ex5-1.htm EX-5.1 6626
3 EXHIBIT 10.1 tm2521015d2_ex10-1.htm EX-10.1 300652
4 EXHIBIT 23.2 tm2521015d2_ex23-2.htm EX-23.2 2398
5 EXHIBIT 23.3 tm2521015d2_ex23-3.htm EX-23.3 2091
6 EX-FILING FEES tm2521015d2_ex-filingfees.htm EX-FILING FEES 10675
7 GRAPHIC tm2521015d2_ex23-2img01.jpg GRAPHIC 4376
8 GRAPHIC tm2521015d2_ex23-2img02.jpg GRAPHIC 4765
9 GRAPHIC lg_rezolute-4clr.jpg GRAPHIC 8231
10 GRAPHIC tm2521015d2_ex5-1img001.jpg GRAPHIC 12642
  Complete submission text file 0001104659-25-068703.txt   613589
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: S-3 | Act: 33 | File No.: 333-288731 | Film No.: 251131334
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)